搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Sphingopyxis alaskensis Alanine--tRNA ligase (alaS) CSB-YP627864
CSB-EP627864
CSB-BP627864
CSB-MP627864
CSB-EP627864-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L25 (rplY) CSB-YP627865SAAS
CSB-EP627865SAAS
CSB-BP627865SAAS
CSB-MP627865SAAS
CSB-EP627865SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Probable potassium transport system protein kup (kup), partial CSB-YP627866SAAS
CSB-EP627866SAAS
CSB-BP627866SAAS
CSB-MP627866SAAS
CSB-EP627866SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Dihydroorotase (pyrC) CSB-YP627867SAAS
CSB-EP627867SAAS
CSB-BP627867SAAS
CSB-MP627867SAAS
CSB-EP627867SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Kynurenine formamidase (kynB) CSB-YP627868SAAS
CSB-EP627868SAAS
CSB-BP627868SAAS
CSB-MP627868SAAS
CSB-EP627868SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Elongation factor P (efp) CSB-YP627869SAAS
CSB-EP627869SAAS
CSB-BP627869SAAS
CSB-MP627869SAAS
CSB-EP627869SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Lipoyl synthase (lipA) CSB-YP627870SAAS
CSB-EP627870SAAS
CSB-BP627870SAAS
CSB-MP627870SAAS
CSB-EP627870SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP627871SAAS
CSB-EP627871SAAS
CSB-BP627871SAAS
CSB-MP627871SAAS
CSB-EP627871SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis ATP synthase subunit a (atpB), partial CSB-YP627872SAAS
CSB-EP627872SAAS
CSB-BP627872SAAS
CSB-MP627872SAAS
CSB-EP627872SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Putative Holliday junction resolvase (Sala_0925) CSB-YP627873SAAS
CSB-EP627873SAAS
CSB-BP627873SAAS
CSB-MP627873SAAS
CSB-EP627873SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C (gatC) CSB-YP627874SAAS
CSB-EP627874SAAS
CSB-BP627874SAAS
CSB-MP627874SAAS
CSB-EP627874SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 30S ribosomal protein S4 (rpsD) CSB-YP627875SAAS
CSB-EP627875SAAS
CSB-BP627875SAAS
CSB-MP627875SAAS
CSB-EP627875SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis UPF0060 membrane protein Sala_0701 (Sala_0701) CSB-YP627876
CSB-EP627876
CSB-BP627876
CSB-MP627876
CSB-EP627876-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Translation initiation factor IF-2 (infB), partial CSB-YP627877SAAS
CSB-EP627877SAAS
CSB-BP627877SAAS
CSB-MP627877SAAS
CSB-EP627877SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 30S ribosomal protein S11 (rpsK) CSB-YP627878SAAS
CSB-EP627878SAAS
CSB-BP627878SAAS
CSB-MP627878SAAS
CSB-EP627878SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis DNA ligase (ligA), partial CSB-YP627879SAAS
CSB-EP627879SAAS
CSB-BP627879SAAS
CSB-MP627879SAAS
CSB-EP627879SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP627880SAAS
CSB-EP627880SAAS
CSB-BP627880SAAS
CSB-MP627880SAAS
CSB-EP627880SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Heme A synthase (ctaA), partial CSB-YP627881SAAS
CSB-EP627881SAAS
CSB-BP627881SAAS
CSB-MP627881SAAS
CSB-EP627881SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP627882MAAN
CSB-EP627882MAAN
CSB-BP627882MAAN
CSB-MP627882MAAN
CSB-EP627882MAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacillus flagellatus PKHD-type hydroxylase Mfla_0096 (Mfla_0096) CSB-YP627883
CSB-EP627883
CSB-BP627883
CSB-MP627883
CSB-EP627883-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>